¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå : À¯Çüº°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð, ½ÃÀå Á¡À¯À², ¿¹Ãø(2024-2032³â)
Microfluidic Components Market, By Type, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
»óǰÄÚµå : 1565723
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2024³â 10¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 269 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,482,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,413,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 7,792,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 59¾ï 8,043¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2024-2032³â CAGR 12.90%·Î È®´ë

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - ½ÃÀå ¿ªÇÐ

POC(Point of Care) Áø´Ü, Drug Discovery, À¯ÀüüÇÐ ½ÃÀå °³Ã´¿¡ ÀÇÇÑ ¼ö¿ä Áõ°¡°¡ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇÒ Àü¸Á

¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Àåºñ´Â Ç÷¾× °Ë»ç, COVID-19¿Í °°Àº Áúº´ Áø´Ü, ¸¸¼ºÁúȯ ¸ð´ÏÅ͸µ°ú °°Àº ÇöÀå °Ë»ç(POCT)¿¡ Á¡Á¡ ´õ ¸¹ÀÌ »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ºü¸£°í Á¤È®ÇÑ ÈÞ´ë¿ë Áø´ÜÀ» °¡´ÉÇÏ°Ô ÇÕ´Ï´Ù. ¸ÂÃãÇü ÇöÀå ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ®¿¡ ´ëÇÑ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. Á¦¾àȸ»çµéÀº ¹ÝÀÀÀ» Á¤È®ÇÏ°Ô Á¦¾îÇÒ ¼ö ÀÖ°í ÇÊ¿äÇÑ ½Ã¾àÀÇ ¼ö¸¦ ÁÙÀÏ ¼ö ÀÖÀ¸¹Ç·Î ¾à¹°ÀÇ ½ºÅ©¸®´×, Á¦ÇüÈ­ ¹× °Ë»ç¿¡ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º°øÇÐÀ» Ȱ¿ëÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½Å¾à °³¹ß Áõ°¡´Â º¸´Ù ºü¸£°í ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ Çʿ伺°ú ÇÔ²² ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ®ÀÇ ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù.

¶ÇÇÑ Æ¯È÷ ´ç´¢º´ ¸ð´ÏÅ͸µ°ú °°Àº ¸¸¼ºÁúȯÀ» À§ÇÑ È¨ÇコÄÉ¾î ¼Ö·ç¼ÇÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀº ¿þ¾î·¯ºí ±â±â ¹× °¡Á¤¿ë Áø´Ü ŰƮ¿¡ ÅëÇյǰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀº À¯Àüü ¹× ´Ü¹éÁúüÇÐ¿Í °°Àº ÷´Ü ¿¬±¸ ºÐ¾ß, ƯÈ÷ ½ÃÄö½Ì, DNA ºÐ¼® ¹× °í󸮷® ½ºÅ©¸®´×°ú °°Àº ÷´Ü ¿¬±¸ ºÐ¾ß¿¡ ÇʼöÀûÀÔ´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ °Ë»ç ¹× ¿¬±¸ ºÐ¾ßÀÇ Á¤¹Ð¼º, ¼Óµµ ¹× ÀÚµ¿È­¿¡ ´ëÇÑ ¿ä±¸´Â ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¼úÀ» ¹ßÀü½Ã۰í ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - ÁÖ¿ä ÀλçÀÌÆ®

´ç»çÀÇ ¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®°¡ °øÀ¯ÇÑ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2024-2032³â) µ¿¾È ¸Å³â ¾à 12.90%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

À¯Çüº° ¼¼ºÐÈ­¸¦ ±âÁØÀ¸·Î ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ĩ ºÎ¹®Àº OoC(Organ On Chip)¿Í °°Àº ÷´Ü ±â¼úÀÇ È°¿ëÀ¸·Î ÀÎÇØ 2023³â¿¡ °¡Àå ³ôÀº ½ÃÀå Á¡À¯À²À» º¸¿´½À´Ï´Ù.

¿ëµµº°·Î º¸¸é POC °Ë»ç ¹× ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä·Î ÀÎÇØ POC Áø´Ü ºÐ¾ß°¡ 2023³â ÁÖ¿ä ¿ëµµ·Î ºÎ»óÇß½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â POC °Ë»ç ¹× Áø´ÜÀÌ ÇÊ¿äÇÑ ¾Ï ¹× ´ç´¢º´ Ä¡·á ¼ö¿ä Áõ°¡·Î ÀÎÇØ º´¿ø ¹× Ŭ¸®´ÐÀÌ 2023³â ÁÖ¿ä ÃÖÁ¾»ç¿ëÀÚ·Î ºÎ»óÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2023³â ÁÖ¿ä ¼öÀÔ¿øÀÌ µÉ °ÍÀ¸·Î ¿¹»óµÇ´Âµ¥, ÀÌ´Â ½Å¾à°³¹ßÀÇ Ã·´Ü ±â¼ú µµÀÔ¿¡ ±âÀÎÇÕ´Ï´Ù.

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - ¼¼ºÐÈ­ ºÐ¼® :

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ¼¼°è ½ÃÀåÀº À¯Çü, ¾ÖÇø®ÄÉÀ̼Ç, ÃÖÁ¾»ç¿ëÀÚ ¹× Áö¿ª¿¡ µû¶ó ¼¼ºÐÈ­µË´Ï´Ù.

¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ĩ, ¸¶ÀÌÅ©·ÎÆßÇÁ, ¸¶ÀÌÅ©·Î ¹ëºê, ¸¶ÀÌÅ©·Î´Ïµé, ±âŸ. ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ĩ ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¿ÂĨ Àå±â °Ë»çÀÇ ±â¼ú Çõ½ÅÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ ºÎ¹®ÀÇ ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù.

ÀÌ ½ÃÀåÀº ¿ëµµ¿¡ µû¶ó POC(Point of Care) Áø´Ü, ¾à¹°Àü´Þ ½Ã½ºÅÛ, ȯ°æ ¸ð´ÏÅ͸µ, ±âŸ 4°³ Ä«Å×°í¸®·Î ³ª´¹´Ï´Ù. ÇöÀå Áø´Ü ºÐ¾ß°¡ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ½Å¼ÓÇÑ Áø´Ü °Ë»ç¿Í ºü¸¥ ºÐ¼®ÀÌ ½ÃÀå ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀåÀº ÃÖÁ¾»ç¿ëÀÚº°·Î º´¿ø ¹× Ŭ¸®´Ð, ¿¬±¸±â°ü, ±âŸ ¼¼ °¡Áö·Î ºÐ·ùµË´Ï´Ù. º´¿ø ¹× Ŭ¸®´Ð ºÎ¹®ÀÌ ½ÃÀåÀ» Áö¹èÇϰí ÀÖÀ¸¸ç, ¿¹Ãø ±â°£ Áß ³ôÀº ¿ìÀ§¸¦ À¯ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áø´Ü Åø¿¡¼­ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Àåºñ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ÀÌ ºÎ¹®ÀÇ ¼ºÀåÀ» º¸¿ÏÇϰí ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - Áö¿ªÀû ÀλçÀÌÆ®

Áö¿ªÀûÀ¸·Î´Â ºÏ¹Ì, ¶óƾ¾Æ¸Þ¸®Ä«, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡ ºÐÆ÷µÇ¾î ÀÖ½À´Ï´Ù. ºÏ¹Ì´Â ¼¼°è ¹Ì¼¼ À¯Ã¼ ½ÃÀå¿¡¼­ °¡Àå Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ¹Ì±¹Àº ÷´Ü ÀÇ·á ½Ã½ºÅÛ, ±â¼ú Çõ½Å ¹× °¡Á¤ Áø´ÜÀÇ ´ë±Ô¸ð µµÀÔÀ¸·Î ÀÌ Áö¿ª ½ÃÀåÀ» µ¶Á¡Çϰí ÀÖ½À´Ï´Ù. À¯·´Àº ½Å¾à°³¹ß, Á¤¹ÐÀÇ·á, Àå±â¿ÂĨ ±â¼ú¿¡ ÁýÁßÇϸ鼭 ²ÙÁØÇÑ ¼ºÀåÀ» º¸À̰í ÀÖ½À´Ï´Ù. ¾Æ½Ã¾Æ¿¡¼­´Â Áß±¹°ú ÀϺ»ÀÌ À¯Àüü, Áø´Ü, ½Å¾à°³¹ß¿¡ ´ëÇÑ ÅõÀÚ¸¦ ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖÀ¸¸ç, Àεµ´Â ÀÇ·á½Ã½ºÅÛÀÇ ¼ºÀå°ú Àúºñ¿ë Á¦Á¶ ´É·ÂÀ» ¹ÙÅÁÀ¸·Î ºÎ»óÇϰí ÀÖ½À´Ï´Ù.

¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - °æÀï ±¸µµ:

¸¶ÀÌÅ©·ÎÀ¯Ã¼ ºÎǰ ½ÃÀåÀº °æÀïÀÌ Ä¡¿­Çϸç, ¸¹Àº ÁÖ¿ä ±â¾÷ÀÌ °æÀï ¿ìÀ§¸¦ È®º¸Çϱâ À§ÇØ ¿¬±¸°³¹ß°ú Àü·«Àû Á¦ÈÞ¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ±â¾÷Àº ½Å¾à °³¹ß, ÇÏÀ̽º·çDz ½ºÅ©¸®´×, ¸ÂÃãÇü ÀÇ·á¿¡ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ç÷§ÆûÀ» Ȱ¿ëÇϱâ À§ÇØ Á¦¾à»ç¿ÍÀÇ Á¦ÈÞ¸¦ ´Ã¸®°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ±â¾÷Àº ´ëÇÐ ¹× ¿¬±¸¼Ò¿Í Çù·ÂÇÏ¿© ƯÈ÷ À¯ÀüüÇÐ, ´Ü¹éÁúüÇÐ, Áø´ÜÇÐ ºÐ¾ßÀÇ ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ¿¬±¸¸¦ ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î BD Biosciences´Â ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ¿Í Çù·ÂÇÏ¿© ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ±â¹Ý ÀÓ»ó Áø´Ü ÅøÀ» °³¹ßÇϰí ÀÖ½À´Ï´Ù.

2023³â, ÆÛŲ¿¤¸Ó´Â ¼¼Æ÷ ºÐ¼® ¹× ½Å¾à°³¹ßÀ» À§ÇÑ ÃֽЏ¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º Ç÷§ÆûÀ» ¹ßÇ¥Çß½À´Ï´Ù.

Agilent Technology´Â 2022³â ¾×ü Å©·Î¸¶Åä±×·¡ÇÇ ¹× ´Ü¹éÁúüÇи¦ À§ÇÑ »õ·Î¿î ¸¶ÀÌÅ©·ÎÇ÷çÀ̵ñ½º ÅøÀ» ¹ßÇ¥Çß½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ®ÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® »ê¾÷ Á¶»ç

Á¦5Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå ±¸µµ

Á¦7Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - À¯Çüº°

Á¦8Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - ¿ëµµº°

Á¦9Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ½ÃÀå - Áö¿ªº°

Á¦11Àå ÁÖ¿ä º¥´õ ºÐ¼® - ¸¶ÀÌÅ©Ç÷çÀ̵ñ ÄÄÆ÷³ÍÆ® ¾÷°è

Á¦12Àå ¾Ö³Î¸®½ºÆ®ÀÇ Àü¹æÀ§ Àü¸Á

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Microfluidic Components Market size was valued at USD 5,980.43 Million in 2023, expanding at a CAGR of 12.90% from 2024 to 2032.

Microfluidic components are the essential building blocks used to manipulate and control fluids at a very small scale, typically in channels with dimensions ranging from tens to hundreds of micrometers. Microfluidic systems enable precise control of tiny fluid volumes in the range of picolitres to microliters, and they are used in various applications such as biological assays, chemical reactions, drug discovery, and diagnostics.

Microfluidic Components Market- Market Dynamics

Rising demand from point-of-care diagnostics, drug discovery and developments in genomics is expected to propel market demand

Microfluidic devices are increasingly being used for point-of-care testing (POCT), such as blood tests, disease diagnosis like COVID-19 diseases, and monitoring chronic conditions. These devices enable fast, accurate, and portable diagnostics. The demand for personalized, on-the-spot medical care is driving the need for microfluidic components. Pharmaceutical companies use microfluidics for drug screening, formulation, and testing, as it allows for precise control over reactions and reduces the number of required reagents. Thus, the rise in drug discovery, coupled with the need for faster and cost-effective solutions, supports the growth of microfluidic components.

Furthermore, with the rise of home healthcare solutions, particularly for chronic diseases such as diabetes monitoring microfluidic technologies are being integrated into wearable devices and home diagnostics kits. Additionally, microfluidic technologies are integral in advanced research fields like genomics and proteomics, particularly for sequencing, DNA analysis, and high-throughput screening. Also, the demand for precision, speed, and automation in genetic testing and research is pushing microfluidic technology forward.

Microfluidic Components Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 12.90% over the forecast period (2024-2032)

Based on Type segmentation, the microfluidic chips segment was predicted to show maximum market share in the year 2023, owing to advanced tech utilization like organ-on-chip (OoC).

Based on Application segmentation, point-of-care diagnostics segment was the leading Application in 2023, due to high need for POC testing and monitoring.

Based on End User segmentation, hospital & clinics segment was the leading End User segment in 2023, due to increasing demand for treatment of cancer, diabetes that need POC testing & diagnosis.

On the basis of region, North America was the leading revenue generator in 2023, due to the adoption of advanced technology in drug discoveries.

Microfluidic Components Market- Segmentation Analysis:

The Global Microfluidic Components Market is segmented on the basis of Type, Application, End User, and Region.

The market is divided into five categories based on Type: microfluidic chips, micropumps, microvalves, microneedles, and others. The microfluidic chips segment dominates the market. Increasing innovation in on-chip organ testing is contributing to segment growth.

The market is divided into four categories based on Application: point-of-care diagnostics, drug delivery systems, environmental monitoring, and others. The point-of-care diagnostics segment dominates the market. Rapid diagnostic testing and quick analysis is boosting market growth.

The market is divided into three categories based on End User: hospital & clinics, research institutes, and others. The hospital & clinics segment dominates the market and is expected to maintain its high dominance during the forecast period. Increasing demand for microfluidic devices in diagnostic tools is supplementing segment growth.

Microfluidic Components Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America holds the largest share in the global microfluidics market. The U.S. dominates the regional market due to its advanced healthcare system, technological innovation, and large-scale adoption of home-based diagnostics. Europe is witnessing Steady growth, with a focus on drug discovery, precision medicine, and organ-on-chip technology. In Asia, China and Japan lead the market, driven by investments in genomics, diagnostics, and drug discovery, while India is emerging due to a growing healthcare system and low-cost manufacturing capabilities.

Microfluidic Components Market- Competitive Landscape:

The microfluidic components market is highly competitive, with numerous key players investing in research, development, and strategic collaborations to gain a competitive edge. Companies are increasingly partnering with pharmaceutical firms to leverage microfluidic platforms for drug discovery, high-throughput screening, and personalized medicines. Major players collaborate with universities and research labs to advance microfluidic research, particularly in genomics, proteomics, and diagnostics. For example, BD Biosciences is partnering with healthcare providers to develop microfluidic-based clinical diagnostics tools.

In 2023, Perkin Elmer introduced updated advanced microfluidic platforms for cell analysis and drug discovery.

In 2022, Agilent Technologies launched new microfluidic tools for liquid chromatography and proteomics.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MICROFLUIDIC COMPONENTS MARKET KEY PLAYERS

GLOBAL MICROFLUIDIC COMPONENTS MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

GLOBAL MICROFLUIDIC COMPONENTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

GLOBAL MICROFLUIDIC COMPONENTS MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

GLOBAL MICROFLUIDIC COMPONENTS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

Table of Contents

1. Microfluidic Components Market Overview

2. Executive Summary

3. Microfluidic Components Key Market Trends

4. Microfluidic Components Industry Study

5. Microfluidic Components Market: COVID-19 Impact Analysis

6. Microfluidic Components Market Landscape

7. Microfluidic Components Market - By Type

8. Microfluidic Components Market - By Application

9. Microfluidic Components Market - By End User

10. Microfluidic Components Market- By Geography

11. Key Vendor Analysis- Microfluidic Components Industry

12. 360 Degree Analyst View

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â